Operating Lease, Right-of-Use Asset of Cocrystal Pharma, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cocrystal Pharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Cocrystal Pharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,468,000, a 17% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cocrystal Pharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,468,000 -$299,000 -17% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $1,545,000 -$128,000 -7.7% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $1,620,000 -$144,000 -8.2% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $1,694,000 -$157,000 -8.5% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $1,767,000 +$1,656,000 +1492% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $1,673,000 +$1,506,000 +902% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $1,764,000 +$1,543,000 +698% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $1,851,000 +$1,577,000 +576% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $111,000 -$216,000 -66% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $167,000 -$211,000 -56% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $221,000 -$207,000 -48% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $274,000 -$204,000 -43% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $327,000 -$199,000 -38% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $378,000 -$25,000 -6.2% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $428,000 -$23,000 -5.1% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $478,000 -$20,000 -4% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $526,000 -$18,000 -3.3% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $403,000 -$186,000 -32% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $451,000 -$183,000 -29% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $498,000 -$179,000 -26% 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q3 2020 $544,000 -$176,000 -24% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 $589,000 -$172,000 -23% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $634,000 -$168,000 -21% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 $677,000 31 Dec 2019 10-K 17 Mar 2021 2020 FY
Q3 2019 $720,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $761,000 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $802,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.